ArticlePediatric radiology2025
Endovascular management of acute portal vein thrombosis in pediatric liver transplant recipients less than 20 kg.
Article in Pediatric radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric recipients of orthotopic liver transplants are at risk for post-transplant complications, particularly acute portal vein thrombosis, which jeopardizes patient survival and graft function. The incidence and impact of portal vein thrombosis are more severe in children compared to adults, with those under 5 most vulnerable to thrombotic events.
objectiveThis study aims to report our institutional experience with endovascular interventions for treating portal vein thrombosis in 11 pediatric liver transplant recipients who presented within 30-days post-transplant. MATERIALS AND
methodsAn IRB-approved retrospective review was conducted on pediatric patients (< 18 years of age) from a single tertiary care institution who received an orthotopic liver transplant and were diagnosed with acute (< 30 days) portal vein thrombosis, from July 2019 to April 2022. Patient demographics, procedural characteristics, and outcomes were recorded.
resultsEleven patients were treated with percutaneous recanalization at a median of 6-days post-transplant for portal vein thrombosis. Median age at the time of transplant was 1.1 years (range 0.64 to 2.14), weight of 8.7 kg (range 6.1 to 18.9 kg), and body mass index of 18.2 (range 14.5 to 21.9). Portal venous access was obtained via trans-hepatic (n = 6) or trans-splenic (n = 4), or both (n = 1) under ultrasound guidance. Mechanical thrombectomy (n = 3), balloon angioplasty (n = 11), and pulse-spray tPA (n = 3) were performed to restore flow to the portal system. Technical success was achieved in all cases (n = 11). The median reduction in portal venous pressure gradient was 10 mmHg (range 4 to 15). One-year primary patency was 70% (7/10), primary-assisted was 100% (1/1), and secondary patency was 100% (3/3). There were no immediate procedure-related complications.
conclusionAcute post-transplant portal vein thrombosis is a significant complication following pediatric liver transplantation with high morbidity. In the early post-transplant period, endovascular interventions to restore portal flow are safe and can produce durable results.
Indexed as
Identifiers
39953299What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.